Children’s Hospital at Montefiore Einstein

Children's Hospital at Montefiore Einstein (CHAM) is a cornerstone in pediatric healthcare, annually serving a diverse community of over 200,000 children and spearheading advancements in medical research and education. Since 2001, with $441 million in research funding, including more than $200 million from the National Institutes of Health (NIH), CHAM has maintained its position as a leader in pediatric research. As a premier academic institution, CHAM is committed to cultivating future pediatric leaders with a curriculum focused on quality improvement, ethics, health equity and social justice, ensuring the highest standard of care for all children.

DATA & STATISTICS

2024 by the numbers

Illustration of man walking up rising bar graph

160K+

children in the community received care

5K+

pediatric emergency department visits

240+

peer-reviewed papers published

$353M

secured in research funding, including more than $200M from NIH

 

Team News

Updates and additions to our world-renowned faculty

John Amodio, MD

Chief, Pediatric Radiology

Brenda Anosike, MD, MPH

Director, Pediatric Fellowship Program

Elisa I. Muñiz, MD

Chief, Developmental Medicine

Punita Ponda, MD

Chief, Pediatric Allergy and Immunology

Advancing pediatric healthcare through research

Annually, CHAM provides care for over 8,000 hospitalized infants, children and adolescents with complex conditions, including 1,200 in its pediatric critical care unit and around 1,000 critically ill newborns in neonatal intensive care units. Additionally, nearly 200,000 children are treated through pediatric ambulatory care, and 44,000 receive care in school-based health programs.

CHAM is recognized for groundbreaking research leading to new therapies and better outcomes. In 2024, CHAM received over $48 million in grants and contracts, with $15 million from the NIH, ranking it among the top 35 institutions for pediatric disease funding nationally.

Clinical Trials

Advancing care through clinical trials

Children's Hospital at Montefiore Einstein participates in both national and clinical trials, a selection of which are highlighted below.

An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases (EBVision)

David Loeb

Phosphate Binder Therapy and Chronic Kidney Disease in Children

Frederick Kaskel

An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)

Deepa Manwani

TrialNet Pathway to Prevention of T1D

Lisa Underland

Testing the Feasibility of a Teletherapy Plus Parent Coaching Intervention for Children With Autism

Elizabeth Ridgway

A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Leslie Delfiner

Patient referrals

At Children’s Hospital at Montefiore Einstein (CHAM), we know that providing patients with the best possible care includes teamwork and trust. We work closely with our valued referring physicians to ensure open communication and reliable expertise.

 

Visit us

Children’s Hospital at Montefiore Einstein  
3415 Bainbridge Ave
Bronx, NY 10467